share_log

B of A Securities Upgrades Novavax to Neutral, Raises Price Target to $12

B of A Securities Upgrades Novavax to Neutral, Raises Price Target to $12

Bof A证券将Novavax上调至中性,将目标股价上调至12美元
Benzinga ·  05/10 13:33

B of A Securities analyst Alec Stranahan upgrades Novavax (NASDAQ:NVAX) from Underperform to Neutral and raises the price target from $4 to $12.

B of A Securities分析师亚历克·斯特拉纳汉将Novavax(纳斯达克股票代码:NVAX)从表现不佳上调至中性,并将目标股价从4美元上调至12美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发